Erlotinib
In Stock•Starting at $10 for 250 mg•Purity ≥ 95%
| CAS No. | 183321-74-6 |
|---|---|
| MDL No. | MFCD02089651 |
| MF | C22H23N3O4 |
| MW | 393.40 |
| InChI Key | AAKJLRGGTJKAMG-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 250 mg | 95% | $10 | In Stock | |
| 1 g | 95% | $12 | In Stock | |
| 5 g | 95% | $34 | In Stock | |
| 25 g | 95% | $140 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Erlotinib is a quinazoline compound with a (3-ethynylphenyl)amino group at the 4-position and two 2-methoxyethoxy groups at the 6- and 7-positions. It functions as an antineoplastic agent, protein kinase inhibitor, and epidermal growth factor receptor antagonist. It belongs to quinazolines, terminal acetylenic compounds, aromatic ethers, and secondary amines.
| CAS No. | 183321-74-6 |
|---|---|
| Product Name | Erlotinib |
Biological Targets
EGFR
Associated Conditions
neoplasm·colorectal cancer·triple-negative breast cancer·anaplastic oligodendroglioma·pancreatic neoplasm·
* The information provided here is compiled from public sources and is for reference only.
